Return vs. Strategy
This article was originally published in Start Up
Executive Summary
Corporate venture funds walk a fine line between investing to access cutting edge technology and investing for return. But now SR One, SmithKline Beecham's in-house venture fund, can have it both ways. With venture firm Euclid Partners, SR One has formed a new $200 million fund, EuclidSR Partners, with SmithKline Beecham contributing a significant amount of money as a limited partner.